Aktuelle Rheumatologie 2004; 29(2): 92-100
DOI: 10.1055/s-2004-813065
Originalarbeit

© Georg Thieme Verlag KG Stuttgart · New York

Verhaltensmedizinische Behandlungsstrategien der Fibromyalgie: Review

Pain Treatment Strategies of Behavioral Medicine in Fibromyalgia: A ReviewK. Thieme1
  • 1Department of Anesthesiology, University of Washington, Seattle, USA
Further Information

Publication History

Publication Date:
21 April 2004 (online)

Zusammenfassung

Das zunehmend bessere Verständnis des Phänomens Schmerz ist mit der Entwicklung zahlreicher neuer medizinisch-somatischer sowie verhaltensmedizinischer Interventionen einhergegangen. Die vorliegende Arbeit gibt einen Überblick über aktuelle ätiopathogenetische Erkenntnisse des Fibromyalgie-Syndroms, die auf der Basis des „Dynamischen Prozessmodells der Fibromyalgie” im Zusammenhang betrachtet werden. Neben zentralnervösen, autonomen und endokrinen Einflussfaktoren auf die Ätiopathogenese der Fibromyalgie wird die Rolle von operanten und kognitiven Lernprozessen bei der Aufrechterhaltung und Verstärkung der Erkrankung aufgezeigt. Im 2. Teil der Arbeit werden verschiedene standardisierte psychologische Therapieformen der Rheumatologie, wie Patientenschulung, Biofeedback, operant- und kognitiv-verhaltenstherapeutische Schmerztherapie, vorgestellt. Erste Studien zu Indikationskriterien der verschiedenen psychologischen Schmerztherapien weisen auf die Individualisierung verhaltensmedizinischer Behandlungsstrategien hin. Metaanalysen weisen die Rolle und die Bedeutsamkeit der psychologischen Schmerztherapie innerhalb eines interdisziplinären Therapieansatzes nach und fordern einen stärkeren Einsatz dieser hocheffektiven psychologischen Therapiemethoden in der rheumatologischen Langzeitbehandlung.

Abstract

Chronic pain is a complex perceptual construct that includes psychosocial and behavioral as well as physiological parameters. The present article reviews the current understanding of etiology and pathogenesis of the specific chronic pain syndrome of fibromyalgia. An integrated dynamic processing model of the fibromyalgia syndrome (FMS) is described incorporating its current understanding. The model integrates neurobiological factors with the role of operant and cognitive behavioral learning principles. The dynamic process model provides a heuristic explanation for the maintenance and reinforcement of the symptoms and disability associated with FMS. The application and utility of patient education, biofeedback, operant- and cognitive behavioral pain treatment are described. Evidence that describes the potential of matching specific treatments to patient characteristics is discussed. The results of meta-analyses demonstrate the role and the relevance of the psychological pain treatment of FMS sufferers and suggest interdisciplinary treatments that incorporate psychological treatments with information and physical exercise are more effective than medical treatments alone.

Literatur

  • 1 Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system.  Lancet. 1995;  345 99-103
  • 2 Arnold L M, Keck P E Jr, Welge J A. Antidepressant treatment of fibromyalgia. A meta-analysis and review.  Psychosomatics. 2000;  41 104-113
  • 3 Arntz A, Dressen L, Merckelbach H. Attention, not anxiety, influences pain.  Behavior Research and Therapy. 1991;  29 41-50
  • 4 Astin J A, Meeker B, Bernhard G. et al .Use of complementary and alternative medicine among rheumatology patients: result of a national survey. Proceedings of the 127th Annual Meeting of the American Public Health Association Chicago, IL; 1999
  • 5 Bandura A, O’Leary A, Barr T aylor C. et al . Perceived self-efficacy and pain control: opioid and nonopioid mechanisms.  Journal of Personality and Social Psychology. 1987;  53 563-571
  • 6 Bennett R M, Clark S R, Campell S M. et al . Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain.  Arthritis & Rheumatism. 1992;  35 1113-1116
  • 7 Bennett R M, Clark S R, Walzyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.  American Journal of Medicine. 1998;  104 227-231
  • 8 Born J, Brauninger W, Fehm-Wolfsdorf G. et al . Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4 - 10.  Exp Brain Res. 1987;  67 85-92
  • 9 Born J, Fehm-Wolfsdorf G, Voigt K H. et al . Cortisol effects on attentional processes in man as indicated by event-related potentials.  Physiol Behav. 1987;  39 83-87
  • 10 Born J, Muth S, Fehm H L. The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol.  Psychoneuroendocrinology. 1988;  13 233-243
  • 11 Bradley L A, McKendree-Smith N L, Alberts K R. et al . Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia.  Curr Rheumatol Rep,. 2000;  2 141-8
  • 12 Brown G K, Nicassio P M. Development of a questionnaire for the assessment of active and passive coping strategies in chronic pain patients.  Pain. 1987;  31 53-64
  • 13 Burckhardt C S, Clark S R, O’Reilly C A. et al . Pain-coping strategies of women with fibromyalgia: relationship to pain, fatigue, and quality of life.  Journal of Musculoskeletal Pain. 1997;  5 5-21
  • 14 Catley D, Kaell A T, Kirschbaum C. et al . A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis.  Arthritis care and research. 2000;  13 51-61
  • 15 Council J R, Ahern D K, Follick M J. et al . Expectancies and functional impairment in chronic low back pain.  Pain. 1988;  33 323-340
  • 16 Crisson J E, Keefe F J. The relationship of locus of control to pain coping strategies and psychological distress in chronic pain patients.  Pain. 1988;  35 147-154
  • 17 Crofford L J. The Hypothalamic-Pituitary-Adrenal Stress-Axis in the Fibromyalgia-syndrome.  J Musculoskelet Pain. 1996;  4 181-200
  • 18 Crofford L J, Demitrack M A. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome.  Rheum-Dis-Clin-North-Am. 1996;  22 267-284
  • 19 Demjen S, Bakal D A. Subjective distress accompanying headache attacks: Evidence for a cognitive shift.  Pain. 1986;  25 194-197
  • 20 Demjen S, Bakal D A, Dunn B E. Cognitive correlates of headache intensity and duration.  Headache. 1990;  30 423-427
  • 21 Dolce J J, Doleys D M, Raczynski J M. et al . The role of self-efficacy expectancies in the prediction of pain tolerance.  Pain. 1986;  27 261-272
  • 22 Dolce J J. Self-efficacy and disability beliefs in behavioral treatment of pain.  Behav Res Ther. 1987;  25 289-299
  • 23 Ehlebracht-Konig I. Qualitätsmanagement in der rheumatologischen Rehabilitation in einer Zeit der strukturellen Veränderungen.  Z Rheumatol. 1998;  57 420-423
  • 24 Eisenberg D M, Davis R B, Ettner S L. et al . Trends in alternative medicine use in the United States, 1990 - 1997: Results of a follow-up national survey.  JAMA. 1998;  280 1569-1575
  • 25 Elam M, Johansson G, Wallin B G. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity?.  Pain. 1992;  48 371-375
  • 26 Fehm-Wolfsdorf G, Born J. Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10 years of research.  Peptides. 1991;  12 1399-1406
  • 27 Fehm-Wolfsdorf G, Nagel D. Differential effects of glucocorticoids on human auditory perception.  Biol Psychol. 1996;  5 (42) 117-130
  • 28 Fehm-Wolfsdorf G, Scheible E, Zenz H. et al . Taste thresholds in man are differentially influenced by hydrocortisone and dexamethasone.  Psychoneuroendocrinol. 1989;  14 433-440
  • 29 Fehm-Wolfsdorf G, Soherr U, Arndt R. et al . Auditory reflex thresholds elevated by stress-induced cortisol secretion.  Psychoneuroendocrinol. 1993;  18 579-589
  • 30 Fernandez E, Turk D C. The utility of cognitive coping strategies for altering pain perception: A meta-analysis.  Pain. 1989;  38 123-135
  • 31 Flor H, Behle D J, Birbaumer N. Assessment of pain-related cognitions in chronic pain patients.  Beh Res Ther. 1993;  31 63-73
  • 32 Flor H, Birbaumer N. Psychobiologie und interdisziplinäre Therapie chronischer Wirbelsäulensyndrome. München; GSF, Forschungszentrum 1994: 22-45
  • 33 Flor H, Birbaumer N. Comparison of the efficacy of the electromyographic biofeedback, cognitive-behavioral therapy, and conservative medical interventions in the treatment of chronic musculosceletal pain.  J Consult Clin Psychol. 1993;  61 653-658
  • 34 Flor H, Breitenstein C, Birbaumer N. et al . A psychophysiological analysis of spouse solitousness towards pain behaviors, spouse interaction and pain perception.  Behav Therapy. 1995;  26 255-272
  • 35 Flor H, Fydrich T, Turk D C. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review.  Pain. 1992;  21 195-202
  • 36 Flor H, Kerns R D, Turk D C. The role of spouse reinforcement, perceived pain, and activity levels of chronic pain patients.  J Psychosom Res. 1987;  31 251-259
  • 37 Flor H, Knost B, Birbaumer N. The role of operant conditioning in chronic pain: an experimental investigation.  Pain. 2002;  95 111-118
  • 38 Flor H, Turk D C. Rheumatoid arthritis and back pain: predicting pain and disability from cognitive variables.  J Behav Med. 1988;  11 251-265
  • 39 Fordyce W E, Roberts A H, Sternbach R A. The behavioral management of chronic pain: A response to critics.  Pain. 1985;  2 113-125
  • 40 Fordyce W E. Behavioral methods in chronic pain and illness. St. Louis; Mosby 1976: 22-32
  • 41 Fordyce W E. Pain and Suffering.  Am Psychol. 1988;  43 276-283
  • 42 Fordyce W E, Lansky D, Calsyn D A. et al . Pain measurement and pain behavior.  Pain. 1984;  18 53-69
  • 43 Gotzsche P C. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.  Control Clinical Trials. 1989;  10 31-56
  • 44 Gracely R H, Petzke F, Wolf J M. et al . Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.  Arthritis Rheum. 2002;  46 1333-1343
  • 45 Graven-Nielsen T, Arendt-Nielsen L, Svensson P. et al . Quantification of local and referred muscle pain in humans after sequential i. m. injections of hypertonic saline.  Pain. 1997;  69 111-117
  • 46 Griep E N, Boersma J W, de-Kloet E P. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome.  J Rheumatol. 1994;  21 2125-2130
  • 47 Griep E N, Boersma J W, Lentjes E G. et al . Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.  J Rheumatol. 1998;  25 1374-1381
  • 48 Heim C, Ehlert U, Hellhammer D H. The potential role of hypocorticolism in the pathophysiology of stress-related bodily disorders.  Psychoneuroendokrin. 2000;  25 1-35
  • 49 Holsboer F, Grasser A, Friess E. et al . Steroid effects on central neurons and implications for psychiatric and neurological disorders.  Ann N Y Acad Sci. 1994;  746 345-359
  • 50 Hrycaj P, Stratz T, Muller W. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome.  J Rheumatol. 1993;  20 1986-1988
  • 51 Jacobson N S, Follette W C, Revenstorf D. Psychotherapy outcome research: methods for reporting variability and evaluating clinical significance.  Behav Ther. 1984;  15 336-352
  • 52 Jensen M P, Karoly P. Control beliefs, coping efforts, and adjustment to chronic pain.  J Consult Clin Psychol. 1991;  59 431-438
  • 53 Kaye R L, Hammond A H. Understanding rheumatoid arthritis. Evaluation of a patient education program.  JAMA. 1978;  239 2466-2467
  • 54 Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenetic mechanisms.  Pain. 1996;  68 375-383
  • 55 Labus J S, Keefe F J, Jensen M P. Self-reports of pain intensity and direct observations of pain behavior: when are they correlated?.  Pain. 2003;  102 109-124
  • 56 Lackner J M, Carosella A M, Feuerstein M. Pain expectancies, pain and functioning self-efficacy expectancies as determinants of disability in patients with chronic low back disorders.  Journal of Consulting and Clinical Psychology. 1996;  64 212-220
  • 57 Langer H E. Patientenschulung - ein Beitrag zur Verbesserung der Langzeitbehandlung der Patienten mit Rheumatismus.  Z Rheumatol. 1995;  54 207-212
  • 58 Langer H E, Birth U. Patientenschulung bei chronischer Polyarthritis. 2. Organisation und Curriculum des Patientenseminars fuer chronische Polyarthritis.  Z Rheumatol. 1987;  46 333-338
  • 59 Langer H E, Birth U. Patientenschulung bei chronischer Polyarthritis. 3. Ergebnisse einer prospektiven, kontrollierten Effektivitätsstudie und Nebenwirkungen des Patientenseminars für Polyarthritispatienten.  Z Rheumatol. 1988;  47 43-51
  • 60 Langer H E, Ehlebracht-Konig I, Mattussek S. Qualitätssicherung in der rheumatologischen Patientenschulung.  Z Arztl Fortbild Qualitätssich. 2003;  97 357-363
  • 61 Lindroth Y, Bauman A, Barnes C. et al . A controlled evaluation of arthritis education.  Br J Rheumatol. 1989;  28 7-12
  • 62 Linton S J. Behavioral remediation of chronic pain: A status report.  Pain. 1986;  24 125-141
  • 63 Litt M D. Self-efficacy and perceived control: Cognitive mediators of pain tolerance.  Journal of Personality and Social Psychology. 1988;  54 149-160
  • 64 Lorenz J, Grasedyck K, Bromm B. Middle and long latency somatosensory evoked potentials after painful laser simulation in patients with fibromyalgia syndrome.  Electroencephalogr Clin Neurophysiol. 1996;  100 165-168
  • 65 Lorenz J. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome.  Z Rheumatol. 1998;  57 19-22
  • 66 Lorig K R. Arthritis self-management: a patient education program.  Rehabil Nurs. 1982;  7 16-20
  • 67 Lorig K, Holman H R. Long-term outcomes of an arthritis self-management study: effects of reinforcement efforts.  Soc Sci Med. 1989;  29 221-224
  • 68 Lorig K R, Holman H. Self-management education: history, definition, outcomes, and mechanisms.  Ann Behav Med. 2003;  26 1-7
  • 69 Lorig K, Konkol L, Gonzalez V. Arthritis patient education: a review of the literature.  Patient Educ Couns. 1987;  10 207-252
  • 70 Lorig K R, Laurent D D, Deyo R A. et al . Can a Back Pain E-mail Discussion Group improve health status and lower health care costs? A randomized study.  Arch Intern Med. 2002;  162 792-796
  • 71 Lorig K R, Mazonson P D, Holman H R. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs.  Arthritis Rheum. 1993;  36 439-446
  • 72 Lorig K, Seleznick M, Lubeck D. et al . The beneficial outcomes of the arthritis self-management course are not adequately explained by behavior change.  Arthritis Rheum. 1989;  32 91-95
  • 73 Lorish C D, Boutaugh M L. Patient education in rheumatology.  Curr Opin Rheumatol. 1997;  9 106-111
  • 74 Lorish C D, Parker J, Brown S. Effective patient education. A quasi-experiment comparing an individualized strategy with a routinized strategy.  Arthritis Rheum. 1985;  28 1289-1297
  • 75 Lousberg R, Schmidt A JM, Groenman N H. The relationship between spouse solicitousness and pain behavior: searching for more experimental evidence.  Pain. 1992;  51 75-79
  • 76 Maes M, Lin A, Bonaccorso S. et al . Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia.  Acta Psychiatric Scandinavia. 1998;  98 328-333
  • 77 McCaul K D, Malott J M. Distraction and coping with pain.  Psychol Bull. 1984;  95 516-533
  • 78 McDermid A J, Rollman G B, McCain G A. Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification.  Pain. 1996;  66 133-144
  • 79 Morris V, Cruwys S, Kidd A. Increased capsaicin-induced secondary hyperalgesia as a marker of abnormal sensory activity in patients with fibromyalgia.  Neurosci Lett. 1998;  250 205-207
  • 80 Mountz J M, Bradley L A, Modell J G. et al . Fibromyalgia in women. Abnormalities of regional blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels.  Arthritis Rheum. 1995;  38 926-938
  • 81 Neeck G, Riedel W. Neuromediator and hormonal pertubations in fibromyalgia syndrome: results of chronic stress?.  Baillière’s Clin Rheumatol. 1994;  8 763-775
  • 82 Nicassio P M, Radojevic V, Weisman M H. et al . A comparison of behavioral and educational interventions for fibromyalgia.  J Rheumatol. 1997;  24 2000-2007
  • 83 Nielson W R, Walker C, McCain G A. Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings.  J Rheumatol. 1992;  19 98-103
  • 84 Nørregard J, Bulow P M, Lykkegaard J J. et al . Muscle strength, working capacity and effort in patients with fibromyalgia.  Scand J Rehabil Med. 1997;  29 97-102
  • 85 Novy D M, Nelson D V, Turk D C. et al . Perspectives of chronic pain: an evaluative comparison of restrictive and comprehensive models.  Psychological Bulletin. 1995;  118 238-247
  • 86 Okifuji A, Turk D C. Fibromyalgia: Search for mechanism and effective treatment. Gatchel RJ, Turk DC Psychosocial factors in pain: Critical perspectives New York; Guilford Press 1999: 227-246
  • 87 Papadopoulos I A, Georgiou P E, Katsimbri P P. et al . Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study.  Clin Rheumatol. 2000;  19 6-8
  • 88 Paulsen J S, Altmaier E M. The effects of perceived versus enacted social support on the discriminative cue function of spouse for pain behaviors.  Pain. 1995;  60 103-110
  • 89 Qiao Z G, Vaeroy H, Morkrid L. Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acustic stimulation and cold pressure tests.  J Rheumatol. 1991;  18 1383-1389
  • 90 Ramos-Remus C, Salcedo-Rocha A L, Prieto-Parra R E. et al . How important is patient education?.  Baillieres Best Pract Res Clin Rheumatol. 2000;  14 689-703
  • 91 Reul J M, HM, Bilang-Bleuel A. et al . New mode of hypothalamic-pituitary-adrenocortical axis regulation: significance for stress-related disorders.  Z Rheumatol. 2000;  59 II/22-II25
  • 92 Riedel W, Layka H, Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones.  Z Rheumatol. 1998;  57 81-87
  • 93 Romano J M, Turner J A, Friedman L S. et al . Sequential Analysis of Chronic Pain Behaviors and Spouse Responses.  J Consult Clin Psychol. 1992;  60 777-782
  • 94 Rossy L A, Buckelew S P, Dorr N. et al . A meta-analysis of fibromyalgia treatment interventions.  Ann Behav Med. 1999;  21 180-191
  • 95 Russel I J. Neurochemical pathogenesis of fibromyalgia.  Zeitschrift für Rheumatologie. 1998;  57 63-66
  • 96 Schmidt A JM. Cognitive factors in the performance level of chronic low back pain patients.  J Psychosom Res. 1985;  29 183-189
  • 97 Sinclair V G, Wallston K A. Predictors of improvement in a cognitive-behavioral intervention for women with rheumatoid arthritis.  Ann Behav Med. 2001;  23 291-297
  • 98 Smith A J. The analgesic effects of selective serotonin reuptake inhibitors.  J Psychopharmacol. 1998;  12 407-413
  • 99 Snow-Turek A L, Norris M P, Tan G. Active and passive coping strategies in chronic pain patients.  Pain. 1996;  64 455-462
  • 100 Sorensen J, Graven-Nielson T, Henriksson K G. et al . Hyperexcitability in fibromyalgia.  J Rheumatol. 1998;  25 152-155
  • 101 Sullivan M JL, Stanish W, Waite H. et al . Catastrophizing, pain, and disability in patients with soft-tissue injuries.  Pain. 1998;  77 253-260
  • 102 Svebak S, Anjia R, Karstad S I. Task-induced electromyographic activation in fibromyalgia subjects and controls.  Scandinavien J Rheumatol. 1993;  22 124-130
  • 103 Thieme K, Gromnica-Ihle E, Flor H. Operant behavioral treatment of fibromyalgia: A controlled study.  Arthritis Rheum/Arthritis Care Res. 2003;  49 314-320
  • 104 Thieme K. et al . Das SLE - Patientenschulungsprogramm - Programminhalt und erste Evaluationsergebnisse.  Akt Rheum. 1997;  22 : 3 1-7
  • 105 Thieme K for the group „SLE-patient education programme” . Evaluation of the SLE- patient education programme (1).  Arthritis Rheum. 1997;  40 (9) (Suppl): 71
  • 106 Thieme K for the group SLE-patient education programme” . Evaluation of the SLE- patient education programme (2).  Arthritis Rheum. 1998;  41 (9) (Suppl): 89
  • 107 Thieme K, Turk D C, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: Relationship to somatic and psychosocial variables (submitted for publication). 
  • 108 Thieme K, Turk D C, Flor H. Indication criteria for the operant and for the cognitive-behavioral pain treatment in fibromyalgia (submitted for publication). 
  • 109 Turk D C, Flor H. Primary fibromyalgia > tender points: toward a multiaxial taxonomy.  J Rheumatol. 1989;  16 80-86
  • 110 Turk D C, Okifuji A, Sinclair J D. et al . Pain, disability and physical functioning of patients with fibromyalgia.  J Rheumatol. 1996;  23 1255-1262
  • 111 Turk D C, Okifuji A, Sinclair J D. et al . Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance.  Arthritis Care Res. 1998;  11 186-195
  • 112 Vaeroy H, Helle R, Forre O. et al . Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.  Pain. 1988;  32 21-26
  • 113 Vaeroy H, Qiao Z G, Morkrid L. et al . Altered sympathetic nervous system response in patients with fibromyalgia.  J Rheumatol. 1989;  16 1460-1465
  • 114 van Denderen J C, Boersma J W, Zeinstra P. et al . Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?.  Scandinavien J Rheumatol. 1992;  21 35-37
  • 115 Vignos P J, Parker W T, Thompson H M. Evaluation of a clinic education program for patients with rheumatoid arthritis.  J Rheumatol. 1976;  3 155-165
  • 116 Vlayen J WS, Van Eek H, Groenman N H. et al . Dimensions and components of observed chronic pain behavior.  Pain. 1987;  31 65-75
  • 117 Vlaeyen J WS, Pernot D, Kole-Snijders A MJ. et al . Assessment of the components of observed chronic pain behavior: the Checklist for Interpersonal Pain Behavior (CHIP).  Pain. 1990;  43 337-347
  • 118 Wolfe F, Anderson J, Harkness D. et al . A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia.  Arthritis Rheum. 1997;  40 1560-1570
  • 119 Wolfe F, Russell I J, Vipraio G. et al . Serotonin levels, pain threshold and fibromyalgia symptoms in the general population.  J Rheumatol. 1997;  243 555-559
  • 120 Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis and fibromyalgia.  Arthritis Rheum. 2000;  43 378-385
  • 121 Woolf C J, Mannion R J. Neuropathic pain: aetiology, symptoms, mechanisms, and management.  Lancet. 1999;  353 1959-1964
  • 122 Wüst S, Federenko I, Hellhammer D H. et al . Genetic factors, perceived chronic stress and the free cortisol response to awakening.  Psychoendocrinol. 2000;  25 707-720
  • 123 Zautra A J, Hoffman J M, Matt K S. et al . An examination of individual differences in the relationship between interpersonal stress and disease activity among women with rheumatoid arthritis.  Arthritis Care Res. 1998;  11 (4) 271-279
  • 124 Zidar J, Backman E, Bengtsson A. et al . Quantitative EMG and muscle tension in painful muscles in fibromyalgia.  Pain. 1990;  40 249-254
  • 125 Zink A, Huscher D, Listing J. Die Kerndokumentation der Regionalen Rheumazentren als Instrument für klinische Epidemiologie und Qualitätsmessung in der Rheumatologie.  Z Arztl Fortbild Qualitätssich. 2003;  97 399-405

Dipl.-Psych. Dr. Kati Thieme

Department of Anesthesiology, University of Washington

1959 NE Pacific Street

BOX 356540

Seattle, Washington 98195-6540

USA

Email: Thiemek@u.washington.edu

    >